verified SJR 0,172 · Q3 • database Scopus / SJR & Web of Science indexed

Poland · Polish Pharmaceutical Societ...

workspace_premium Q3 — Pharmacology lock_open Open Access

Acta Poloniae Pharmaceutica

Acta Poloniae Pharmaceutica is a journal indexed in SJR in Pharmacology and Pharmaceutical Science with an H index of 53. It has an SJR impact factor of 0,172 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,172.

ISSN: 0001-6837

Publisher: Polish Pharmaceutical Society

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,172 Q3

H-index 53

Acceptance rate pie_chart

31%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Open Access

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,172

H-index

Docs (year)

Docs 3y

296

Total refs

3263

Cites 3y

134

Citable 3y

294

Cites/Doc 2y

0.39

Ref/Doc

47.29

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

BIOLOGICAL ACTIVITY AND POLYPHENOL CONTENT IN SELECTED HERBAL TEA BLENDS USED IN DIABETES

Visualizing reagents for the identification and the examination of the identity of diclofenac

Cyanidin and peonidin inhibit SPCA-1 growth in vitro via inducing Cell Cycle Arrest and Apoptosis

COMPOSITION AND BIOMEDICAL RELEVANCE OF SEA BUCKTHORN

COMBINATIONS OF ISOTHIOCYANATES WITH DRUGS -A CHANCE OR THREAT TO CHEMOPREVENTION AND CANCER TREATMENT?

COMBINATION OF BERBERINE AND MATRINE AFFECTS APOPTOSIS AND CELLCYCLE IN HUMAN CERVICAL CANCER CELLS

CIRSIUM OLERACEUM L. SCOP. INHIBITS CELL VIABILITY AND DECREASES SECRETION OF MATRIX METALLOPROTEINASES (MMP2 AND MMP9) IN GLIOBLASTOMA CELL LINE

Chemical transformations of glucose in solutions for peritoneal dialysis after sterilization and during storage

Chemical composition, antimicrobial and cytotoxic activity of essential oils of Algerian Thymus vulgaris L.

CHEMICAL COMPOSITION OF THE ESSENTIAL OIL AND FLAVONOIDS OF THYMUS SERPYLLUM L., GROWING ON TERRITORY OF THE EAST KAZAKHSTAN

CANNABINOIDS AS ANTIEMETICS: A SHORT REVIEW

Bridging East with West of Europe -a comparison of orphan drugs policies in Poland, Russia and the Netherlands

SHOW MORE ARTICLES

BOX BEHNKEN DESIGN: A STATISTICAL APPROACH TO EVALUATE THE EFFECT OF CROSSLINKED CARBOXYMETHYL CELLULOSE AND SODIUM STARCH GLYCOLATE ON RELEASE KINETICS OF DRUG

"Selective arylation of phenol proteted propygyl bromide via pd-catalysed Suzuki coupling reaction: synthesis, mechanistic studies by DFT calculations and Their Pharmacological Aspects"

APPLICABILITY OF THE EVIDEM MULTI-CRITERIA DECISION ANALYSIS FRAMEWORK FOR ORPHAN DRUGS -RESULTS FROM A STUDY IN 7 EURASIAN COUNTRIES.

ANTIPSYCHOTICS AND LOW VITAMIN D -ADDITIONAL DATA CALLING FOR DRUG CAUSALITY ASSESSMENT

ANTINOCICEPTIVE AND ANTIANXIETY ACTIVITY OF HYDROETHANOLIC EXTRACTS OF THREE IMPATIENS SPECIES IN MICE

ANALYTICAL PROCEDURE ELABORATION OF TOTAL FLAVONOID CONTENT DETERMINATION AND ANTIMICROBIAL ACTIVITY OF BEE BREAD EXTRACTS

AMELIORATIVE EFFECTS OF DIMETHYL FUMARATE IN ACUTE AND CHRONIC MURINE MODELS OF DEPRESSION

ALLIUM URSINUM L. LEAVES COMPONENTS MODIFIED THE PHYSICO-CHEMICAL PROPERTIES OF RED BLOOD CELLS PROTECTING THEM FROM THE EFFECTS OF OXIDATIVE STRESS

ADVANCES AND LIMITATIONS IN PHARMACOTHERAPY OF EPILEPSY

A therapeutic potential of nicotine: reassessing the current paradigm of nicotine pharmacotherapy, literature review.

A REVIEW ON CYCLAMEN SPECIES:

A policy view: gaps and weaknesses of substitution between biological products in law and economics dimension: the example of insulin

FAQs

Acta Poloniae Pharmaceutica has an SJR of 0,172 (best quartile Q3) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Acta Poloniae Pharmaceutica is 31%.

Acta Poloniae Pharmaceutica

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Acta Poloniae Pharmaceutica?

What is the APC / publication cost?

What is the acceptance rate?